Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Somatic Disease Among Alcohol Abusers in an Out-day Patients' Clinic

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Havard Dalen, Levanger Hospital
ClinicalTrials.gov Identifier:
NCT01081197
First received: March 4, 2010
Last updated: May 2, 2013
Last verified: May 2013

March 4, 2010
May 2, 2013
March 2010
December 2012   (final data collection date for primary outcome measure)
Prevalence of different kinds of somatic disease [ Time Frame: 3 months after inclusion ] [ Designated as safety issue: No ]
Prevalence of somatic disease at study attendance of any kind, specified for heart disease, gall- and liver disease, neuropathic disease.
Same as current
Complete list of historical versions of study NCT01081197 on ClinicalTrials.gov Archive Site
  • Prevalence of former somatic disease [ Time Frame: 3 months after inclusion ] [ Designated as safety issue: No ]
    Prevalence of former somatic disease investigated by anamnestic examination, search in patient journals and communication with the patients community health service.
  • Outcome of psychiatric and somatic treatment of alcohol abusers [ Time Frame: 1 year after stopped inclusion ] [ Designated as safety issue: No ]
    Quality of life and score of somatic and psychiatric health 1 year after inclusion
Same as current
Not Provided
Not Provided
 
Somatic Disease Among Alcohol Abusers in an Out-day Patients' Clinic
Somatic Disease Among Alcohol Abusers in an Out-day Patients' Clinic. A Neglected Area

Alcohol abuse is associated with a variety of clinical diseases, but studies on prevalence of different somatic diseases among alcohol abusers are lacking. Studies on populations in an out-day patients' clinic are also lacking.

The investigators aim to study somatic health standard in an out-day patients' clinic population of alcohol abusers, with regard to prevalence of different kinds of somatic diseases, and how the interaction of somatic and psychiatric treatment can influence on patients quality of life. Clinical examination including blood samples and echocardiographic examinations in all participants, other additional examinations (as x-ray, CT or MRI if indicated by clinical findings).

Retrospective methods will be used to study former somatic disease, cross-section design to study present somatic disease and prospective design to study quality of life, psychiatric and somatic health after combination of psychiatric and somatic examinations and treatment.

Observational
Observational Model: Cohort
Not Provided
Retention:   Samples Without DNA
Description:

Conventional blood samples including i.e. glycosylated haemoglobin, serum ferritin, serum gamma-GT, B-type natriuretic peptide.

Non-Probability Sample

Alcohol abusers referred to the out-day patients' clinic at Dep. of Psychiatry, Levanger Hospital, Norway

  • HEART DISEASE
  • Liver Failure
  • DEPRESSIVE DISORDER
  • Alcoholic Neuropathy
Other: Psychiatric and somatic examinations and ,if clinical indicated, treatment
Patients referred to the clinic will be given optimal treatment for revealed psychiatric and/or somatic disease including conversational therapy, and if indicated therapeutic interventions with respect to any kind of disease.
  • Out-day patients' clinic
    Alcohol abusers referred to out-day patients' clinic which consent to participate in the study
    Intervention: Other: Psychiatric and somatic examinations and ,if clinical indicated, treatment
  • Control
    Control group for the cardiac arm of the study will be matched controls from the Nord-Trøndelag Health Study (HUNT)

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
150
May 2013
December 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Alcohol abusers reffered to the out-day patients' clinic at Dep. of Psychiatry, Levanger Hospital, Norway

Exclusion Criteria:

  • Not consenting to participate
  • Not able to consent
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Norway
 
NCT01081197
LE_ARP_Somatic_AlcoholAddicts
No
Havard Dalen, Levanger Hospital
Levanger Hospital
Not Provided
Principal Investigator: Erling Dalen, MD Levanger Hospital
Levanger Hospital
May 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP